Business

Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy

TAMPA, FLORIDA / ACCESS Newswire / August 14, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, ...

articleWellgistics Health, Inc.August 14, 20253/company/wellgistics-health-inc-common-stock/news/wellgistics-health-terminates-equity-line-of-credit-to-further-support-growth-strategy
Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy

About this update from Wellgistics Health, Inc.

[{"type":"text","content":"TAMPA, FLORIDA / ACCESS Newswire / August 14, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the termination of its equity purchase agreement ("ELOC") with Hudson Global Ventures, LLC.","length":389,"tagName":"p"},{"type":"text","content":"The ELOC was an effective tool that nearly doubled the Company's original IPO raise. The decision to terminate the agreement reflects a strategic shift toward accretive financing and reinforces its aim of long-term shareholder value creation.","length":246,"tagName":"p"},{"type":"text","content":"Management cited strong execution in expanding its independent pharmacy network, accelerating adoption of its AI-powered prescription routing technology and payment platforms, and creating a strong pipeline for growth opportunities with manufacturer direct-to-patient (DTP) platforms as drivers behind the move. This unique approach is designed to bypass traditional PBM barriers, increase manufacturer margins, and accelerate patient access.","length":442,"tagName":"p"},{"type":"text","content":""From a financial standpoint, terminating the ELOC aligns with our disciplined approach to capital structure and shareholder equity preservation," said Mark DiSiena, Chief Financial Officer of Wellgistics Health. "It allows us to secure more favorable funding opportunities so we can focus on our strategic plans, optimize our cost of capital, and pursue options that better reflect our growth trajectory."","length":426,"tagName":"p"},{"type":"text","content":""This decision reflects the discipline we're bringing to every part of the business," said Brian Norton, Chief Executive Officer of Wellgistics Health. "We've moved past the challenges of our opening quarters and are entering a new chapter built on operational strength and strategic execution. We're ready to show the market what we're truly capable of - delivering smarter, faster access to medicine, empowering independent pharmacies, and creating lasting value across the healthcare ecosystem."","length":534,"tagName":"p"},{"type":"text","content":"About Wellgistics Health","length":24,"tagName":"p"},...

More updates from Wellgistics Health, Inc.

Forward-Looking StatementsHealthindependent pharmacies